Chargement en cours...
Akt inhibitor MK-2206 enhances the effect of cisplatin in gastric cancer cells
The phosphoinositide 3-kinase/Akt pathway activation commonly occurs in various types of human cancer and has an important role in chemoresistance. Combination of traditional chemotherapy drugs and molecular-targeted agents is a promising strategy for cancer therapy, which has shown enhanced cytotox...
Enregistré dans:
| Publié dans: | Biomed Rep |
|---|---|
| Auteurs principaux: | , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4774399/ https://ncbi.nlm.nih.gov/pubmed/26998277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.594 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|